These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium.
    Author: Neumannova M, Kauppila A, Vihko R.
    Journal: Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973.
    Abstract:
    Endometrial estrogen and progestin receptors were quantitatively measured in the cytosol (ERc, PRc) and nuclear (ERn, PRn) fractions, the activity of 17 beta-hydroxysteroid dehydrogenase measured in 13 normal women in the late proliferative phase of the cycle (control group), in 33 patients with adenocarcinoma, and in 6 patients with other malignancies of the endometrium. The parameters measured had relatively small variations in the control group, whereas the opposite was true for the malignant endometrium. ERc and PRc were present in significantly higher concentrations in normal endometrial tissue (167 and 1697 fmol/mg cytosol protein, respectively) than in malignant endometrial tissue (45 and 116 fmol/mg cytosol protein, respectively), and the ratios of ERc/ERn and PRc/PRn were higher (P much less than .001 in both cases) in the normal group. The activities of 17 beta-hydroxysteroid dehydrogenase were identical in normal and adenocarcinoma tissue and correlated with PRc in carcinomatous endometrium. The present results support previous findings that the great majority of endometrial adenocarcinoma specimens have significant concentrations of ERc and PRc and that these concentrations are lower than in normal endometrium. In addition, they demonstrate that nuclear location of the female sex steroid receptors is favored in the malignant tissue. Despite these differences, the 17 beta-hydroxysteroid dehydrogenase activities were identical in proliferative endometrium and in endometrial adenocarcinoma.
    [Abstract] [Full Text] [Related] [New Search]